Daxor (DXR) Other Long-Term Liabilities

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DXR Daxor Corp DXR
47 GF Score
Price $10.20
GF Value $37.53
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Daxor Other Long-Term Liabilities?

Other Long-Term Liabilities does not apply to banks and insurance companies.

DXR
47GF Score
Daxor Corp DXR
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Daxor (DXR) Overvalued in 2026?

Based on GuruFocus' analysis, Daxor stock appears to be undervalued. The current stock price of $10.20 is trading 72.8% below its estimated GF Value™ of $37.53. GuruFocus considers Daxor to be Possible Value Trap.

Key valuation signals for DXR:

  • Other Long-Term Liabilities:
  • GF Value™: $37.53 vs. price of $10.20 (72.8% below fair value)
  • GF Score™: 47/100 with 1 warning sign

No single metric tells the full story. See the DXR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daxor Business Description

Other Exchanges DX5:Germany
Address 107 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
47GF Score

Get the complete analysis for DXR

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.20
Price
$37.53
GF Value